Kyverna Therapeutics Inc. (KYTX)
undefined
undefined%
At close: undefined
4.42
0.23%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21
Revenue - 7.03M 5.66M
Cost of Revenue 1.71M 1.05M 586.00K
Gross Profit -1.71M 5.97M 5.07M
Operating Income -62.41M -29.38M -26.35M
Interest Income 2.28M 565.00K 1K
Pretax Income -60.37M -28.89M -26.35M
Net Income -60.37M -28.89M -26.35M
Selling & General & Admin 12.48M 8.01M 6.15M
Research & Development 49.92M 28.40M 25.85M
Other Expenses - -9.00K -2.00K
Operating Expenses 62.41M 36.41M 32.00M
Interest Expense 187.00K 65.00K 3.00K
Selling & Marketing Expenses - - -
Cost & Expenses 62.41M 36.41M 32.00M
Income Tax - 56.00K 1K
Shares Outstanding (Basic) 673.62M 25.80M 25.80M
Shares Outstanding (Diluted) 673.62M 25.80M 25.80M
EPS (Basic) -0.00 -1.12 -1.02
EPS (Diluted) -0.00 -1.12 -1.02
EBITDA -58.47M -27.78M -25.76M
Depreciation & Amortization 1.71M 1.05M 586.00K